drugset / Trial / NCT04615403

Study of Exchange of Travoprost Intraocular Implant

NCT04615403

Phase 2 Completed 33 enrolled Glaukos Corporation
NaSingle-groupOpen-labelTreatment

Summary

The study objective is to evaluate the safety of the operative and surgical exchange procedure of Travoprost Intraocular Implant in subjects with open-angle glaucoma or ocular hypertension.

Timeline

Start
2020-11-19
Primary completion
2022-02-28
Completion
2022-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Travoprost Other / unclassified Other

Indications